CollPlant Biotechnologies (CLGN) Q1 2026 Earnings — Mixed Results

Screener

Reported May 29, 2026 · Before market open

Revenue$73.0KMiss by $387.0K

EPS-$0.23Beat by $0.01

Revenue estimate$460.0K

EPS estimate-$0.24

Next report

Aug 31, 2026 (In 2 days)

Revenue estimate$480.0K

EPS estimate-$0.24

Versus estimates

Revenue

Q1 2026$73.0KMiss by $387.0K

Q4 2025$60.0KMiss by $2.0M Q3 2025$77.0KMiss by $6.7M Q2 2025$179.0KMiss by $16.3M Q1 2025$2.1MMiss by $6.9M Q4 2024$164.0KBeat by $64.0K

Diluted EPS

Q1 2026-$0.23Beat by $0.01

Q4 2025-$0.67Miss by $0.37 Q3 2025-$0.27Miss by $0.65 Q2 2025-$0.28Miss by $0.18 Q1 2025-$0.13Beat by $0.24 Q4 2024-$0.34Beat by $0.08

FAQ

When did CollPlant Biotechnologies report Q1 2026 earnings?: CollPlant Biotechnologies (CLGN) reported Q1 2026 earnings on May 29, 2026 before market open.
What were CollPlant Biotechnologies's Q1 2026 revenue and EPS?: CollPlant Biotechnologies reported revenue of $73.0K and eps of $-0.23 for Q1 2026.
Did CollPlant Biotechnologies beat estimates in Q1 2026?: Revenue missed the consensus estimate of $460.0K by $387.0K. EPS beat the consensus estimate of $-0.24 by $0.01.
How did CollPlant Biotechnologies's Q1 2026 results compare year-over-year?: Compared to the same quarter a year prior, revenue declined 96.4% from $2.1M a year earlier and eps declined 76.9% from $-0.13.

Ask the moment CollPlant Biotechnologies reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk